Gene Expression Profiling of Biopsies
Gene expression profiling of tumor biopsies and liquid biopsies can provide insight into inflammation and overall immune status
Profiling of biopsies by gene expression can serve as a tool for screening tumors that may respond to treatments such as checkpoint inhibitors, for evaluating therapeutic efficacy, for illuminating mechanism of action, and for a range of other applications
Comprehensive and quantitative gene expression profiling
Precision offers gene expression profiling and transcriptomics assays to monitor immune status using next generation sequencing (NGS), NanoString, qPCR, and Droplet Digital™ PCR (ddPCR) technologies. For sample types and needs other than immune profiling of biopsies, Precision also offers a full suite of genomics applications.
Our services are designed to meet your project objectives, whether through pre-existing panels or a customized assay.
Illumina and Thermo Fisher NGS Sequencers
We use both Illumina and Thermo Fisher for next-gen sequencing. Also, RNA-seq studies are done using Illumina, including the AmpliSeq for Illumina Immune Response Panel.
NanoString nCounter®
For highly multiplexed, quantitative gene expression studies, we use the NanoString nCounter® platform. This system directly detects RNA, avoiding the potential for introduced bias with approaches that rely on PCR-based amplification.
We can use NanoString’s immuno-oncology and immunology panels or create a custom panel for your study.
QuantStudio™ 12K flex real-time PCR system
For cost-effective, multiplexed gene expression profiling of many samples in parallel, we offer analyses using OpenArray plates on the QuantStudio 12K Flex qPCR platform.
QX200™ ddPCR™
Digital PCR is appropriate when highly sensitive analyses and absolute quantification is needed. Precision utilizes the Bio-Rad QX200 ddPCR System.
Agena MassARRAY®
High-throughput solution for genotyping, somatic mutation detection, DNA methylation analysis, and gene expression regulation analysis. Precision for Medicine offers MassARRAY® assays either as an individual service or as part of a comprehensive therapeutic development package, which includes biomarker assays and clinical trials.
Precision also provides research-ready biospecimens
In addition to services, Precision has biospecimens ready for genomic analysis, as well as specimens pre-characterized via NGS.
Discuss your project requirements
Precision offers gene expression profiling and transcriptomics assays to monitor immune status using multiple technologies. Talk to an expert about supporting your project.
Explore the Precision blog
Read our blog to gain more insights and discover work that Precision has supported.
Protocol Study Design: Bridging Clinical Goals with Patient Needs
Translational Research - Biomarkers - Assays
Optimizing Immunohistochemistry Validation and Regulatory Strategies
|
Expediting Clinical Trial Study Start-up in Australia
|